Cross-Linked Hyaluronic Acid
Volume Plus HA Dermal Filler
Facial volume · Contouring
Volume Plus is Aphorage Gloryal’s cross-linked hyaluronic acid dermal filler at 24 mg/ml. It is positioned for facial volume restoration and contouring, and is supplied as two 1 ml pre-filled syringes for professional use.
CE-marked product. Contact RAMCODE for regulatory documentation.
HA Concentration
24 mg/ml
Pack Size
2 × 1 ml
Needle Gauge
27G
Indicative Duration
8–12 months
Clinical Application
Treatment Areas
About
Volume Plus Product Overview
Volume Plus contains cross-linked sodium hyaluronate at 24 mg/ml. Within the Aphorage Gloryal portfolio, it is positioned for facial volume restoration and contouring. The supplied catalogue describes a presentation of two 1 ml pre-filled syringes.
Distributors can assess Volume Plus alongside Complete, the biphasic HA filler, to understand the differences within the range. Request current technical documentation for the proposed territory, including the intended use and product specifications.
Explore the full Aphorage Gloryal range or request product and distribution information.
Technical Data
Product Specifications
Specifications are summarised from the supplied product catalogue. Indicative durations are not guaranteed outcomes. Consult the current instructions for use and supporting technical documentation for your territory.
24 mg/ml HA | 27G | BD Syringe | 2 × 1 ml
HA Concentration
24 mg/ml
Composition
Cross-linked HA
Needle Gauge
27G
Indicative Duration
8–12 months
Syringe
BD Syringe
Volume
2 × 1ml
Injection Area
Deep dermis · Subcutaneous · Supraperiosteal
pH
6.5–7.5
BDDE Content
< 2 µg/g
Heavy Metals
< 10 µg/g
Packaging
2 syringes × 1ml pre-filled
Cross-linking
Cross-linked HA
Formulation Information
Cross-Linked HA Formulation
Volume Plus is formulated with cross-linked sodium hyaluronate. Its HA concentration is 24 mg/ml according to the supplied catalogue. For cross-linking specifications, intended use and performance data, consult the current technical documentation rather than inferring clinical properties from the animation.
Explore the portfolio’s HA and PLLA formulations or request technical information.
Conceptual animation — not microscopy or clinical evidence.